NCT03063632 2023-10-25Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial SarcomaNational Cancer Institute (NCI)Phase 2 Completed28 enrolled 15 charts